Environ Health Toxicol.  2012 ;27(1):e2012014.

Lack of Mutagenicity Potential of Periploca sepium Bge. in Bacterial Reverse Mutation (Ames) Test, Chromosomal Aberration and Micronucleus Test in Mice

Affiliations
  • 1Biotoxtech. Co. Ltd., Ochang, Korea.
  • 2Department of Biological Science and the Research Institute for Basic Sciences, Hoseo University, Asan, Korea.
  • 3Fusion Research Laboratory, Hoseo University, Asan, Korea. cbpark@hoseo.edu

Abstract


OBJECTIVES
The root barks of Periploca sepium Bge. (P. sepium) has been used in traditional Chinese medicine for healing wounds and treating rheumatoid arthritis. However, toxicity in high-doses was often diagnosed by the presence of many glycosides. The potential mutagenicity of P. sepium was investigated both in vitro and in vivo.
METHODS
This was examined by the bacterial reverse mutation (Ames) test using Escherichia coli WP2uvrA and Salmonella typhimurium strains, such as TA98, TA100, TA1535, and TA1537. Chromosomal aberrations were investigated using Chinese hamster lung cells, and the micronucleus test using mice.
RESULTS
P. sepium did not induce mutagenicity in the bacterial test or chromosomal aberrations in Chinese hamster lung cells, although metabolic activation and micronucleated polychromatic erythrocytes were seen in the mice bone marrow cells.
CONCLUSIONS
Considering these results, it is suggested that P. sepium does not have mutagenic potential under the conditions examined in each study.

Keyword

Reverse mutation; Chromosome aberration; Micronucleus; Mice; Periploca sepium Bge

MeSH Terms

Animals
Arthritis, Rheumatoid
Biotransformation
Bone Marrow
Chromosome Aberrations
Cricetinae
Cricetulus
Erythrocytes
Escherichia coli
Glycosides
Lung
Medicine, Chinese Traditional
Mice
Micronucleus Tests
Periploca
Salmonella typhimurium
Glycosides
Full Text Links
  • EHT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr